Literature DB >> 8124119

Clinicoepidemiological study of drug resistance in Indian kala-azar.

S Sundar1, B B Thakur, A K Tandon, N R Agrawal, C P Mishra, T M Mahapatra, V P Singh.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8124119      PMCID： PMC2539260          DOI： 10.1136/bmj.308.6924.307

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Evaluation of efficacy of longer durations of therapy of fresh cases of kala-azar with sodium stibogluconate.

Authors:  C P Thakur; M Kumar; A K Pandey
Journal:  Indian J Med Res       Date:  1991-03       Impact factor: 2.375

2.  Changing response to diamidine compounds in cases of kala-azar unresponsive to antimonial.

Authors:  S N Jha; N K Singh; T K Jha
Journal:  J Assoc Physicians India       Date:  1991-04

Review 3.  Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies.

Authors:  B L Herwaldt; J D Berman
Journal:  Am J Trop Med Hyg       Date:  1992-03       Impact factor: 2.345
  3 in total
  17 in total

Review 1.  Drug resistance in leishmaniasis.

Authors:  Simon L Croft; Shyam Sundar; Alan H Fairlamb
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  In vitro life cycle of pentamidine-resistant amastigotes: stability of the chemoresistant phenotypes is dependent on the level of resistance induced.

Authors:  D Sereno; J L Lemesre
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

Review 3.  An update on pharmacotherapy for leishmaniasis.

Authors:  Shyam Sundar; Jaya Chakravarty
Journal:  Expert Opin Pharmacother       Date:  2014-10-25       Impact factor: 3.889

4.  Drug resistance in leishmaniasis.

Authors:  Jaya Chakravarty; Shyam Sundar
Journal:  J Glob Infect Dis       Date:  2010-05

5.  Short-Course Treatment Regimen of Indian Visceral Leishmaniasis with an Indian Liposomal Amphotericin B Preparation (Fungisome™).

Authors:  Rama P Goswami; Rudra P Goswami; Sukhen Das; Aditya Satpati; Mehebubar Rahman
Journal:  Am J Trop Med Hyg       Date:  2015-11-02       Impact factor: 2.345

6.  Immune complex antigens as a tool in serodiagnosis of kala-azar.

Authors:  Tapati Chakraborti; Dwijen Sarkar; Dilip K Ghosh
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

7.  Gene expression profiling and molecular characterization of antimony resistance in Leishmania amazonensis.

Authors:  Rubens L do Monte-Neto; Adriano C Coelho; Frédéric Raymond; Danielle Légaré; Jacques Corbeil; Maria N Melo; Frédéric Frézard; Marc Ouellette
Journal:  PLoS Negl Trop Dis       Date:  2011-05-24

8.  Use of antimony in the treatment of leishmaniasis: current status and future directions.

Authors:  Arun Kumar Haldar; Pradip Sen; Syamal Roy
Journal:  Mol Biol Int       Date:  2011-06-08

9.  In vitro sensitivity of paired Leishmania (Viannia) braziliensis samples isolated before meglumine antimoniate treatment and after treatment failure or reactivation of cutaneous leishmaniasis.

Authors:  Cibele Baptista; Luciana de Freitas Campos Miranda; Maria de Fátima Madeira; Leonor Laura Pinto Leon; Fátima Conceição-Silva; Armando de Oliveira Schubach
Journal:  Dis Markers       Date:  2015-01-31       Impact factor: 3.434

Review 10.  Drug resistance in visceral leishmaniasis.

Authors:  Helena C Maltezou
Journal:  J Biomed Biotechnol       Date:  2009-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.